[1]
|
Bouillet, L. (n.d.) Orphanet: Angio oedème [Internet]. Orphanet. http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=65
|
[2]
|
Bowen, T., Cicardi, M., Farkas, H., et al. (2010) International Consensus Algorithm for the Diagnosis, Therapy and Management of Hereditary Angioedema. Allergy, Asthma & Clinical Immunology, 6, 24. https://doi.org/10.1186/1710-1492-6-24
|
[3]
|
Grigoriadou, S. and Longhurst, H.J. (2009) Clinical Immunology Review Series: An Approach to the Patient with Angio-Oedema. Clinical & Experimental Immunology, 155, 367-377. https://doi.org/10.1111/j.1365-2249.2008.03845.x
|
[4]
|
Inomata, N. (2012) Recent Advances in Drug-Induced Angioedema. Allergology International, 61, 545-557. https://doi.org/10.2332/allergolint.12-RAI-0493
|
[5]
|
Cicardi, M., Aberer, W., Banerji, A., Bas, M., Bernstein, J.A., Bork, K., et al. (2014) Classification, Diagnosis, and Approach to Treatment for Angioedema: Consensus Report from the Hereditary Angioedema. Allergy, 69, 602-616. https://doi.org/10.1111/all.12380
|
[6]
|
Agostoni, A. and Cicardi, M. (2001) Drug-Induced Angioedema without Urticaria. Drug Safety, 24, 599-606. https://doi.org/10.2165/00002018-200124080-00004
|
[7]
|
Pecquet, C. (2003) OEdème de Quincke. Ann Dermatol Venerol, 130, 219-224.
|
[8]
|
Andrejak, M. (2010) Angioedèmes, IEC et sartans. Thérapeutiques en Dermato-Vénérologie. Cahier 1.
|
[9]
|
Bouillet, L., Ponard, D., Dumestre, C., et al. (2000) L’oedème angioneurotique acquis: Caractéristques cliniques et biologiques chez neuf patients. Presse Med, 29, 640-644.
|
[10]
|
Frémeaux-Bacchi, V., Dragon-Durey, M.-A., Blouin, J., Mouthon, L. and Fridman, W.H. (2003) Le complément en médecine interne. Ann Med Int, 154, 529-540.
|
[11]
|
André, C., André, F., Veysseyre-Balter, C. and Rousset, H. (2003) OEdème angioneurotique acquis induit par la contraception hormonale. Presse Med.
|
[12]
|
Drouet, C., Ponard, D. and Bouillet, L. (2006) Angio-oedèmes iatrogènes par inhibiteurs de l’enzyme de conversion, antagonistes du récepteur de l’angiotensine, membranes de dialyse. [Iatrogenic Angioedema Due to Estrogen, Angiotensin Conversion Enzyme Inhibitors, Angiotensin Receptor Antagonists and Dialysis Membranes.] La Revue de Médecine Interne, 27, S76-S79. https://doi.org/10.1016/j.revmed.2006.03.012
|
[13]
|
Kostis, J.B., Moreyra, A.E. and Kostis, W.J. (2016) Angioedema with Renin Angiotensin System Drugs and Neutral Endopeptidase Inhibitors. Journal of the American Society of Hypertension, 10, 387-389. https://doi.org/10.1016/j.jash.2016.02.017
|
[14]
|
Cugno, M., Nussberger, J., Cicardi, M. and Agostoni, A. (2003) Bradykinin and the Pathophysiology of Angioedema. International Immunopharmacology, 3, 311-317. https://doi.org/10.1016/S1567-5769(02)00162-5
|
[15]
|
Morimoto, T., Gandhi, T.K., Fiskio, J.M., Seger, A.C., So, J.W., Cook, E.F., Fukui, T. and Bates, D.W. (2004) An Evaluation of Risk Factors for Adverse Drug Events Associated with Angiotensin-Converting Enzyme Inhibitors. Journal of Evaluation in Clinical Practice, 10, 499-509. https://doi.org/10.1111/j.1365-2753.2003.00484.x
|
[16]
|
Agostini, A., Cicardi, M., Cugno, M., Zingale, L.C., Gioffré, D. and Nussberger, J. (1999) Angioedma due to Angiotensin-Converting Enzyme Inhibitors. Immunopharmacology, 44, 21-25. https://doi.org/10.1016/S0162-3109(99)00107-1
|
[17]
|
Cicardi, M., Zingale, L.C., Bergamaschini, L., et al. (2004) Angioedema Associated with Angiotensin-Converting Enzyme Inhibitor Use. Outcome after Switching to a Different Treatment. Archives of Internal Medicine, 164, 910-913. https://doi.org/10.1001/archinte.164.8.910
|
[18]
|
Garcia-Hejl, C., Harnois, F., El Jahiri, Y., Bigaillon, C., Mennecier, D., Ceppa, F., Thiolet, C. and Fabre, R. (2006) Un cas d’oedème angioneurotique acquis. Ann Biol Clin, 64, 166-169.
|
[19]
|
Dumestre-Pérard, C. and Bouillet, L. (2000) Acquisitions récentes concernant une maladie peu fréquente: l’oedème angioneurotique associé à un déficit en C1 inhibiteur. Lyon Pharm, 51, 14-30.
|
[20]
|
Borne, M., Borne-Pons, M., Vincenti-Rouquette, I., Lambert, E. and Diraison, Y. (1999) Oèdème angioneurotique et anesthésie: Préparation, thérapeutique et recommandations périopératoires en 1999. Med Armées, 27, 391-398.
|
[21]
|
Sabroe, R.A. and Black, A.K. (1997) Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiooedema. British Journal of Dermatology, 136, 153-158. https://doi.org/10.1111/j.1365-2133.1997.tb14887.x
|
[22]
|
O’Ryan, F., Poor, D.B. and Hattori, M. (2005) Intraoperative Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: Overview and Case Report. Journal of Oral and Maxillofacial Surgery, 63, 551-556. https://doi.org/10.1016/j.joms.2004.12.010
|
[23]
|
Fain, O., Mekinian, A., Gobert, D., Khau, C.A. and Javaud, N. (2015) [Drug Induced Angioedema (ACE-Inhibitors and Other)]. La Presse Médicale, 44, 43-47. https://doi.org/10.1016/j.lpm.2014.07.019
|
[24]
|
Adam, A., Cugno, M., Molinaro, G., Perez, M., Lepage, Y. and Agostoni, A. (2002) Aminopeptidase P in Individuals with a History of Angio-Oedema on ACE Inhibitors. The Lancet, 359, 2088-2089. https://doi.org/10.1016/S0140-6736(02)08914-6
|
[25]
|
Bouillet, L., Drouet, C., Ponard, D. and Massot, C. (2003) Intérêt du test thérapeutique à l'acide tranexamique dans la prise en charge des angio-oedèmes non allergiques. Rev Méd Interne, 24, Suppl 4.
|